Acadia Pharmaceuticals

Filed a patent for "compositions for the treatment of diseases and conditions" on Wed, August 2, 2023

Filed a patent for "compositions for treatment of diseases and conditions" on Fri, February 16, 2024

Filed a patent for "compositions of trofinetide" on Thu, October 13, 2022

Filed a patent for "single-layer oral dose of neuro-attenuating ketamine" on Fri, August 12, 2022

Filed a patent for "neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods" on Thu, June 22, 2023

Filed a patent for "stable intranasal formulations of carbetocin" on Thu, June 29, 2023

Filed a patent for "modulators of g protein-coupled receptor 88" on Thu, April 25, 2024

Filed a patent for "compounds, salts thereof and methods for treatment of diseases" on Thu, September 22, 2022

Filed a patent for "crystalline forms of trofinetide" on Thu, January 26, 2023